Brad Pohlman
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 104
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 66
- Acute Myeloid Leukemia Research 27
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 39
- Oncology top 1%
- Viral-associated cancers and disorders 35
- Neutropenia and Cancer Infections 18
- CAR-T cell therapy research 18
- Transplantation top 5%
-
- Acute Lymphoblastic Leukemia research 33
Brad Pohlman
216 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Pathology and Forensic Medicine 2.1k
- Hematology 1.1k
- Genetics 904
- Oncology 1.9k
- Transplantation 118
Countries citing papers authored by Brad Pohlman
This map shows the geographic impact of Brad Pohlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Pohlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Pohlman more than expected).
Fields of papers citing papers by Brad Pohlman
This network shows the impact of papers produced by Brad Pohlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Pohlman. The network helps show where Brad Pohlman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brad Pohlman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 4 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 1 | |
| 8 | 2019 | 5 | |
| 9 | 2019 | 1 | |
| 10 | 2017 | 2 | |
| 11 | 2017 | 6 | |
| 12 | 2017 | 1 | |
| 13 | 2017 | 1 | |
| 14 | 2017 | 5 | |
| 15 | 2017 | 1 | |
| 16 | 2014 | 161 | |
| 17 | 2012 | 54 | |
| 18 | 2011 | 91 | |
| 19 | 2009 | 0 | |
| 20 | 2008 | 36 |
About Brad Pohlman
Brad Pohlman is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Oncology and Transplantation, having authored 220 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (104 papers), Hematopoietic Stem Cell Transplantation (66 papers), Chronic Lymphocytic Leukemia Research (39 papers), Viral-associated cancers and disorders (35 papers), Acute Lymphoblastic Leukemia research (33 papers), Acute Myeloid Leukemia Research (27 papers), Neutropenia and Cancer Infections (18 papers) and CAR-T cell therapy research (18 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.1k citations), Hematology (1.1k citations), Genetics (904 citations), Oncology (1.9k citations) and Transplantation (118 citations). Brad Pohlman has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Brian J. Bolwell, Ronald Sobecks, Lisa Rybicki, Eric D. Hsi, M Kalaycio, Robert M. Dean, S Andresen, Leo I. Gordon, Thomas E. Witzig and Christos Emmanouilides. Their work appears in journals such as Blood, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.